Patients with AITL showing more exhausted CD8+TILs should be screened for poor prognosis, especially in case of high CD8+TILs and CTL levels, and the most important and ideal treatment is to recover the effector function of CD8+TILs. This evidence concerns the gene CD8A and angioimmunoblastic T-cell lymphoma.